Cutler Group’s ResMed RMD Stock Holding History

Cutler Group’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-9,500	Closed	-$4K	–	6563
2017 Q2	$4K	Sell	9,500 -3,900	-29%	-$279K	﹤0.01%	5064
2017 Q1	$42K	Buy	+13,400	New	+$926K	﹤0.01%	2588
2016 Q1	–	Sell	-2,300	Closed	-$4K	–	7080
2015 Q4	$4K	Buy	+2,300	New	+$130K	﹤0.01%	5104

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cutler Group's RMD Position: Q3 2017 in Review

Cutler Group sold out of ResMed (RMD) in Q3 2017, closing a stake of 8,624 shares — an estimated $660K sold.

Cutler Group first reported a position in RMD in Q2 2016 and held it in 4 quarters. The position peaked at $673K in Q1 2017. 362 funds tracked by Wall St. Rank hold RMD as of Q3 2017.

Cutler Group reported no remaining ResMed position as of Q3 2017 after selling out during the quarter.
Cutler Group sold 8,624 ResMed shares in Q3 2017, an estimated $660K.
Cutler Group first reported a position in ResMed in Q2 2016 and held it in 4 quarters.
Cutler Group's ResMed position peaked at $673K in Q1 2017.
362 funds tracked by Wall St. Rank held ResMed as of Q3 2017.

Based on Cutler Group's 13F filing for Q3 2017, filed 17 Oct 2017.